Decoding Complexity in Synthetic Oligonucleotides: Unraveling Coeluting Isobaric Impurity Ions by High Resolution Mass Spectrometry
Analyzing coeluting impurities with similar masses in synthetic oligonucleotides by liquid chromatography-mass spectrometry (LC-MS) poses challenges due to inadequate separation in either dimension. Herein, we present a direct method employing fully resolved isotopic envelopes, enabled by high resol...
Uložené v:
| Vydané v: | Analytical chemistry (Washington) Ročník 96; číslo 2; s. 904 |
|---|---|
| Hlavní autori: | , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
United States
16.01.2024
|
| Predmet: | |
| ISSN: | 1520-6882, 1520-6882 |
| On-line prístup: | Zistit podrobnosti o prístupe |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | Analyzing coeluting impurities with similar masses in synthetic oligonucleotides by liquid chromatography-mass spectrometry (LC-MS) poses challenges due to inadequate separation in either dimension. Herein, we present a direct method employing fully resolved isotopic envelopes, enabled by high resolution mass spectrometry (HRMS), to identify and quantify isobaric impurity ions resulting from the deletion or addition of a uracil (U) or cytosine (C) nucleotide from or to the full-length sequence. These impurities may each encompass multiple sequence variants arising from various deletion or addition sites. The method utilizes a full or targeted MS analysis to measure accurate isotopic distributions that are chemical formula dependent but nucleotide sequence independent. This characteristic enables the quantification of isobaric impurity ions involving sequence variants, a capability typically unavailable in sequence-dependent MS/MS methods. Notably, this approach does not rely on standard curves to determine isobaric impurity compositions in test samples; instead, it utilizes the individual isotopic distributions measured for each impurity standard. Moreover, in cases where specific impurity standards are unavailable, the measured isotopic distributions can be adequately replaced with the theoretical distributions (calculated based on chemical formulas of standards) adjusted using experiment-specific correction factors. In summary, this streamlined approach overcomes the limitations of LC-MS analysis for coeluting isobaric impurity ions, offering a promising solution for the in-depth profiling of complex impurity mixtures in synthetic oligonucleotide therapeutics. |
|---|---|
| AbstractList | Analyzing coeluting impurities with similar masses in synthetic oligonucleotides by liquid chromatography-mass spectrometry (LC-MS) poses challenges due to inadequate separation in either dimension. Herein, we present a direct method employing fully resolved isotopic envelopes, enabled by high resolution mass spectrometry (HRMS), to identify and quantify isobaric impurity ions resulting from the deletion or addition of a uracil (U) or cytosine (C) nucleotide from or to the full-length sequence. These impurities may each encompass multiple sequence variants arising from various deletion or addition sites. The method utilizes a full or targeted MS analysis to measure accurate isotopic distributions that are chemical formula dependent but nucleotide sequence independent. This characteristic enables the quantification of isobaric impurity ions involving sequence variants, a capability typically unavailable in sequence-dependent MS/MS methods. Notably, this approach does not rely on standard curves to determine isobaric impurity compositions in test samples; instead, it utilizes the individual isotopic distributions measured for each impurity standard. Moreover, in cases where specific impurity standards are unavailable, the measured isotopic distributions can be adequately replaced with the theoretical distributions (calculated based on chemical formulas of standards) adjusted using experiment-specific correction factors. In summary, this streamlined approach overcomes the limitations of LC-MS analysis for coeluting isobaric impurity ions, offering a promising solution for the in-depth profiling of complex impurity mixtures in synthetic oligonucleotide therapeutics. Analyzing coeluting impurities with similar masses in synthetic oligonucleotides by liquid chromatography-mass spectrometry (LC-MS) poses challenges due to inadequate separation in either dimension. Herein, we present a direct method employing fully resolved isotopic envelopes, enabled by high resolution mass spectrometry (HRMS), to identify and quantify isobaric impurity ions resulting from the deletion or addition of a uracil (U) or cytosine (C) nucleotide from or to the full-length sequence. These impurities may each encompass multiple sequence variants arising from various deletion or addition sites. The method utilizes a full or targeted MS analysis to measure accurate isotopic distributions that are chemical formula dependent but nucleotide sequence independent. This characteristic enables the quantification of isobaric impurity ions involving sequence variants, a capability typically unavailable in sequence-dependent MS/MS methods. Notably, this approach does not rely on standard curves to determine isobaric impurity compositions in test samples; instead, it utilizes the individual isotopic distributions measured for each impurity standard. Moreover, in cases where specific impurity standards are unavailable, the measured isotopic distributions can be adequately replaced with the theoretical distributions (calculated based on chemical formulas of standards) adjusted using experiment-specific correction factors. In summary, this streamlined approach overcomes the limitations of LC-MS analysis for coeluting isobaric impurity ions, offering a promising solution for the in-depth profiling of complex impurity mixtures in synthetic oligonucleotide therapeutics.Analyzing coeluting impurities with similar masses in synthetic oligonucleotides by liquid chromatography-mass spectrometry (LC-MS) poses challenges due to inadequate separation in either dimension. Herein, we present a direct method employing fully resolved isotopic envelopes, enabled by high resolution mass spectrometry (HRMS), to identify and quantify isobaric impurity ions resulting from the deletion or addition of a uracil (U) or cytosine (C) nucleotide from or to the full-length sequence. These impurities may each encompass multiple sequence variants arising from various deletion or addition sites. The method utilizes a full or targeted MS analysis to measure accurate isotopic distributions that are chemical formula dependent but nucleotide sequence independent. This characteristic enables the quantification of isobaric impurity ions involving sequence variants, a capability typically unavailable in sequence-dependent MS/MS methods. Notably, this approach does not rely on standard curves to determine isobaric impurity compositions in test samples; instead, it utilizes the individual isotopic distributions measured for each impurity standard. Moreover, in cases where specific impurity standards are unavailable, the measured isotopic distributions can be adequately replaced with the theoretical distributions (calculated based on chemical formulas of standards) adjusted using experiment-specific correction factors. In summary, this streamlined approach overcomes the limitations of LC-MS analysis for coeluting isobaric impurity ions, offering a promising solution for the in-depth profiling of complex impurity mixtures in synthetic oligonucleotide therapeutics. |
| Author | Hawes, Jessica Kozak, Darby Yang, Kui Zhang, Deyi Sapru, Mohan Rodriguez, Jason D Abdullah, A M Sommers, Cynthia |
| Author_xml | – sequence: 1 givenname: A M surname: Abdullah fullname: Abdullah, A M organization: Division of Complex Drug Analysis, Office of Testing and Research, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, St. Louis, Missouri 63110, United States – sequence: 2 givenname: Cynthia surname: Sommers fullname: Sommers, Cynthia organization: Division of Complex Drug Analysis, Office of Testing and Research, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, St. Louis, Missouri 63110, United States – sequence: 3 givenname: Jason D surname: Rodriguez fullname: Rodriguez, Jason D organization: Division of Complex Drug Analysis, Office of Testing and Research, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, St. Louis, Missouri 63110, United States – sequence: 4 givenname: Deyi surname: Zhang fullname: Zhang, Deyi organization: Division of Therapeutic Performance I, Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland 20903, United States – sequence: 5 givenname: Darby surname: Kozak fullname: Kozak, Darby organization: Division of Therapeutic Performance I, Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland 20903, United States – sequence: 6 givenname: Jessica surname: Hawes fullname: Hawes, Jessica organization: Division of Systems Biology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, Arkansas 72079, United States – sequence: 7 givenname: Mohan surname: Sapru fullname: Sapru, Mohan organization: Division of New Drug Product III, Office of New Drug Product, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland 20903, United States – sequence: 8 givenname: Kui orcidid: 0000-0001-6550-8583 surname: Yang fullname: Yang, Kui organization: Division of Complex Drug Analysis, Office of Testing and Research, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, St. Louis, Missouri 63110, United States |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38158374$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNkDtPwzAYRS1URB_wDxDyyNJiO0kTs6HyaKSiSpTOle18aY0cO8QOIjN_nFYtEtM9w7l3uEPUs84CQteUTChh9E4oPxFWGLWDahIpkhA6PUMDmjAynmYZ6_3jPhp6_0EIpXvpAvWjjCZZlMYD9PMIyhXabvHMVbWBbx06rC1edTbsIGiFl0ZvnW2VARd0Af4er20jvsAcS2DacKDcOymavZ9XddscVnJnPZYdnuvtDr-BdwfTWfwqvMerGlRoXAWh6S7ReSmMh6tTjtD6-el9Nh8vli_57GExFnESh3EcczYlXIpEJGlKooKoCEoZqTTmouCZLCilSqUl51KCKJmMKCcguGCJKoCxEbo97taN-2zBh02lvQJjhAXX-g3jhJMsy_b3jtDNSW1lBcWmbnQlmm7zdxz7BQ7Nd_Y |
| ContentType | Journal Article |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1021/acs.analchem.3c05016 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Engineering Chemistry |
| EISSN | 1520-6882 |
| ExternalDocumentID | 38158374 |
| Genre | Journal Article |
| GroupedDBID | --- -DZ -~X .DC .K2 23M 4.4 53G 55A 5GY 5RE 5VS 6J9 7~N 85S AABXI AAHBH ABBLG ABHFT ABHMW ABJNI ABLBI ABMVS ABOCM ABPPZ ABQRX ABUCX ACBEA ACGFO ACGFS ACGOD ACIWK ACJ ACKOT ACNCT ACPRK ACS ADHLV AEESW AENEX AFEFF AFRAH AGXLV AHGAQ ALMA_UNASSIGNED_HOLDINGS AQSVZ BAANH BKOMP CGR CS3 CUPRZ CUY CVF D0L EBS ECM ED~ EIF F5P GGK GNL IH9 IHE JG~ KZ1 LMP NPM P2P PQQKQ ROL RXW TAE TN5 UHB UI2 UKR VF5 VG9 W1F WH7 X6Y XSW YZZ ZCA ~02 7X8 |
| ID | FETCH-LOGICAL-a454t-4492609ba5a57703d0c3efb3c749ad98bd111cc7f99bbeaf2b3190ea9a25cde22 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 0 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001144043700001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1520-6882 |
| IngestDate | Thu Jul 10 22:07:51 EDT 2025 Mon Jul 21 05:18:15 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-a454t-4492609ba5a57703d0c3efb3c749ad98bd111cc7f99bbeaf2b3190ea9a25cde22 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0000-0001-6550-8583 |
| OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC10794994 |
| PMID | 38158374 |
| PQID | 2909088810 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_2909088810 pubmed_primary_38158374 |
| PublicationCentury | 2000 |
| PublicationDate | 2024-01-16 |
| PublicationDateYYYYMMDD | 2024-01-16 |
| PublicationDate_xml | – month: 01 year: 2024 text: 2024-01-16 day: 16 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Analytical chemistry (Washington) |
| PublicationTitleAlternate | Anal Chem |
| PublicationYear | 2024 |
| SSID | ssj0011016 |
| Score | 2.4480515 |
| Snippet | Analyzing coeluting impurities with similar masses in synthetic oligonucleotides by liquid chromatography-mass spectrometry (LC-MS) poses challenges due to... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 904 |
| SubjectTerms | Chromatography, High Pressure Liquid - methods Drug Contamination Liquid Chromatography-Mass Spectrometry Molecular Weight Oligonucleotides - chemistry Tandem Mass Spectrometry - methods |
| Title | Decoding Complexity in Synthetic Oligonucleotides: Unraveling Coeluting Isobaric Impurity Ions by High Resolution Mass Spectrometry |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/38158374 https://www.proquest.com/docview/2909088810 |
| Volume | 96 |
| WOSCitedRecordID | wos001144043700001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8NAEF7UCurB96O-WMFrNNlsslkvImqxh1ZBhd7KviKFNqmmCj37x51JUvQiCF5CLhuW2dnZb3Ym30fIqWHapgrSEqvC2ONGKy9JmfQYst0Ip3jITSk2IbrdpNeTD_WFW1G3Vc5iYhmobW7wjvycSR9bcpLAvxy_eqgahdXVWkJjnjRCgDLY0iV631UEzExLvlRMkQBKzn6dY8G5MsWZgqUCy4zOQuNHfhD_DjLLw6a19t9prpPVGmbSq8ovNsicyzbJ0vVM3W2TrPwgItwinzeQheIpRjE-IEfmZEoHGX2cZgAQ4Rv0fjh4yTMkP84nA-uKC_qcoXLRsBrk0IHhrV1AfIDQStujcamLR9vg1lRPKTaUUCwWVK5OO4Da6eO4FOEZOZjTNnlu3T5d33m1PIOneMQnHkeuQV9qFalIQOCwvgldqkMjuFRWJtpCHDVGpFJq7VTKNGx33ympWGSsY2yHLGR55vYITRLI6YWANbScC18mPE0cVjh5GFsW8iY5mVm7D3bCmobKXP5e9L_t3SS71ZL1xxVPRx_ASAT5N9__w-gDsswAruDlShAfkkYKm98dkUXzMRkUb8elX8Gz-9D5Ag1824Q |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Decoding+Complexity+in+Synthetic+Oligonucleotides%3A+Unraveling+Coeluting+Isobaric+Impurity+Ions+by+High+Resolution+Mass+Spectrometry&rft.jtitle=Analytical+chemistry+%28Washington%29&rft.au=Abdullah%2C+A+M&rft.au=Sommers%2C+Cynthia&rft.au=Rodriguez%2C+Jason+D&rft.au=Zhang%2C+Deyi&rft.date=2024-01-16&rft.eissn=1520-6882&rft.volume=96&rft.issue=2&rft.spage=904&rft_id=info:doi/10.1021%2Facs.analchem.3c05016&rft_id=info%3Apmid%2F38158374&rft_id=info%3Apmid%2F38158374&rft.externalDocID=38158374 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1520-6882&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1520-6882&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1520-6882&client=summon |